Trudeau Unveils Covid-19 Vaccine Deals with Novavax, J&J
(Bloomberg) -- Canada has agreed to buy more than 100 million Covid-19 vaccines from Novavax Inc. and Johnson & Johnson, Prime Minister Justin Trudeau said Monday.
The new agreements will guarantee as many as 76 million doses of NVX-CoV2373 from Gaithersburg, Maryland-based Novavax and 38 million doses of Ad26.COV2.S from New Brunswick, New Jersey-based Johnson & Johnson, Trudeau told reporters in Ottawa.
“It is possible that there is a breakthrough soon that will allow us to get a vaccine more quickly, but we don't know where or if that breakthrough will come,” Trudeau said. “That's why the government of Canada has moved forward on signing agreements with a broad range of vaccine developers.”
The deals for Covid-19 vaccines add to previously signed procurement agreements with Pfizer Inc., based in New York, for at least 20 million doses and Cambridge, Mass.-based Moderna Inc. for as many as 56 million doses.
Canada will “continue to negotiate and sign other agreements with a number of leading pharmaceutical companies, to ensure the supply of potential vaccines in Canada,” according to a statement from the Prime Minister's Office. There are currently no vaccines approved to prevent Covid-19.
NVX-CoV2373 is currently in Phase 2 testing in countries including the U.S., Australia and South Africa. Novavax said it could provide the vaccine as early as June 2021.
“We are pleased to work with the Canadian government on supply of our COVID-19 vaccine, an essential step to ensure broad access of our vaccine candidate,” Stan Erck, chief executive officer at Novavax, said in a statement. “We are moving forward with clinical development of NVX-CoV2373 with a strong sense of urgency in our quest to deliver a vaccine to protect the world.”
Trudeau also said it was “unfortunate” a deal to develop a vaccine with CanSino Biologics Inc. fell through after China refused to allow their research to be exported to Canada.
As of Aug. 30, Canada had reported 127,940 cases of Covid-19, with 9,117 deaths.
©2020 Bloomberg L.P.
-
We May Need Another Tukaram Mundhe To Fight Air Pollution | The Reason Why
Developers may install basic measures such as sprinklers and green nets, resume work, and continue violating rules when this equipment stops working.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.